Current Issue January 2012, Vol. 8, No. 1

Featured Articles

National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
January 2012 (Vol. 8 | No. 1 | Pages 1-13)
Bradley T. Hyman, Creighton H. Phelps, Thomas G. Beach, Eileen H. Bigio, Nigel J. Cairns, Maria C. Carrillo, Dennis W. Dickson, Charles Duyckaerts, Matthew P. Frosch, Eliezer Masliah, Suzanne S. Mirra, Peter T. Nelson, Julie A. Schneider, Dietmar Rudolf Thal, Bill Thies, John Q. Trojanowski, Harry V. Vinters, Thomas J. Montine
Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's Biomarkers Standardization Initiative
January 2012 (Vol. 8 | No. 1 | Pages 65-73)
Hugo Vanderstichele, Mirko Bibl, Sebastiaan Engelborghs, Nathalie Le Bastard, Piotr Lewczuk, Jose Luis Molinuevo, Lucilla Parnetti, Armand Perret-Liaudet, Leslie M. Shaw, Charlotte Teunissen, Dirk Wouters, Kaj Blennow
[123I]N-ω-fluoropropyl-2β-carbomethoxy-3β-(4-iodophenyl)nortropane single-photon emission computed tomography brain imaging in the diagnosis of dementia with Lewy bodies
January 2012 (Vol. 8 | No. 1 | Pages 74-83)
Zuzana Walker, Jeffrey L. Cummings
Mild cognitive impairment: Disparity of incidence and prevalence estimates
January 2012 (Vol. 8 | No. 1 | Pages 14-21)
Alex Ward, H. Michael Arrighi, Shannon Michels, Jesse M. Cedarbaum
Screening and treatment for Alzheimer's disease: Predicting population-level outcomes
January 2012 (Vol. 8 | No. 1 | Pages 31-38)
Nicolas M. Furiak, Kristin Kahle-Wrobleski, Christopher Callahan, Timothy M. Klein, Robert W. Klein, Eric R. Siemers

Citalopram for agitation in Alzheimer’s disease: Design and methods
03 February 2012
Lea T. Drye, Zahinoor Ismail, Anton P. Porsteinsson, Paul B. Rosenberg, Daniel Weintraub, Christopher Marano, Gregory Pelton, Constantine Frangakis, Peter V. Rabins, Cynthia A. Munro, Curtis L. Meinert, D.P. Devanand, Jerome Yesavage, Jacobo E. Mintzer, Lon S. Schneider, Bruce G. Pollock, Constantine G. Lyketsos, for the CitAD Research Group
Abstract: Background: Agitation is one of the most common neuropsychiatric symptoms of Alzheimer’s disease (AD), and is associated with serious adverse consequences for patients and caregivers. Eviden...
Effects of Food and Drug Administration-approved medications for Alzheimer’s disease on clinical progression
03 February 2012
Michelle M. Mielke, Jeannie-Marie Leoutsakos, Chris D. Corcoran, Robert C. Green, Maria C. Norton, Kathleen A. Welsh-Bohmer, JoAnn T. Tschanz, Constantine G. Lyketsos
Abstract: Background: Observational studies suggest that cholinesterase inhibitors and/or memantine may delay clinical progression of Alzheimer’s disease (AD) in 40% of individuals taking the medicati...
Amyloid imaging in dementias with atypical presentation
30 January 2012
David A. Wolk, Julie C. Price, Charles Madeira, Judy A. Saxton, Beth E. Snitz, Oscar L. Lopez, Chester A. Mathis, William E. Klunk, Steven T. DeKosky
Abstract: Background: With the potential emergence of disease specific therapies, an accurate biomarker of Alzheimer’s Disease pathology is needed in cases in which the underlying etiology is uncertai...
Impact of the Food and Drug Administration’s antipsychotic black box warning on psychotropic drug prescribing in elderly patients with dementia in outpatient and office-based settings
30 January 2012
Vibha C.A. Desai, Pamela C. Heaton, Christina M.L. Kelton
Abstract: Background: Most patients with dementia also suffer from behavioral and psychological symptoms of dementia, for which there is no Food and Drug Administration-approved treatment. Objectives:...
Analysis of case management programs for patients with dementia: A systematic review
30 January 2012
Dominique Somme, Hélène Trouve, Moustapha Dramé, Dominique Gagnon, Yves Couturier, Olivier Saint-Jean
Abstract: Background: People suffering from dementia are particularly vulnerable to the gaps between the health and social service systems. Case management is a professional field that seeks to fill i...

View More Articles in Press...

The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
May 2011 (Vol. 7 | No. 3 | Pages 263-269)
Guy M. McKhann, David S. Knopman, Howard Chertkow, Bradley T. Hyman, Clifford R. Jack, Claudia H. Kawas, William E. Klunk, Walter J. Koroshetz, Jennifer J. Manly, Richard Mayeux, Richard C. Mohs, John C. Morris, Martin N. Rossor, Philip Scheltens, Maria C. Carrillo, Bill Thies, Sandra Weintraub, Creighton H. Phelps
Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
May 2011 (Vol. 7 | No. 3 | Pages 257-262)
Clifford R. Jack, Marilyn S. Albert, David S. Knopman, Guy M. McKhann, Reisa A. Sperling, Maria C. Carrillo, Bill Thies, Creighton H. Phelps
The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
May 2011 (Vol. 7 | No. 3 | Pages 270-279)
Marilyn S. Albert, Steven T. DeKosky, Dennis Dickson, Bruno Dubois, Howard H. Feldman, Nick C. Fox, Anthony Gamst, David M. Holtzman, William J. Jagust, Ronald C. Petersen, Peter J. Snyder, Maria C. Carrillo, Bill Thies, Creighton H. Phelps
Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
May 2011 (Vol. 7 | No. 3 | Pages 280-292)
Reisa A. Sperling, Paul S. Aisen, Laurel A. Beckett, David A. Bennett, Suzanne Craft, Anne M. Fagan, Takeshi Iwatsubo, Clifford R. Jack, Jeffrey Kaye, Thomas J. Montine, Denise C. Park, Eric M. Reiman, Christopher C. Rowe, Eric Siemers, Yaakov Stern, Kristine Yaffe, Maria C. Carrillo, Bill Thies, Marcelle Morrison-Bogorad, Molly V. Wagster, Creighton H. Phelps
2011 Alzheimer’s disease facts and figures
March 2011 (Vol. 7 | No. 2 | Pages 208-244)
Alzheimer’s Association

On the Cover

About the Cover

Publishing Information

Alzheimer's & Dementia: The Journal of the Alzheimer's Association is published by Elsevier for the Alzheimer's Association.

Access this journal onSciVerse ScienceDirect

New Issue Alert

Free Trial Issue

Journal Ranking

About The Alzheimer's Association

The Alzheimer's Association is the leading, global voluntary health organization in Alzheimer care and support, and the largest private, nonprofit funder of Alzheimer research.

The Alzheimer's Association has been recognized as the top large nonprofit to work for and number five in the top 50 nonprofits overall by The NonProfit Times, the leading information provider for the nonprofit sector.

Journal Access

Full-text articles are available from July 2005 to the present. Access to abstracts is complimentary. Access to full text is limited to Alzheimer's Association members as well as personal subscribers.

Activate Online Access

Access Neurobiology of Aging